MedPath

A Phase II Study of Pemetrexed in Elderly Patients with Previously Untreated Non-Squamous Non-Small-Cell Lung Cancer

Phase 2
Conditions
Elderly patients with previously untreated non-squamous non-small cell lung cancer
Registration Number
JPRN-UMIN000003691
Lead Sponsor
ung Cancer Experts Network
Brief Summary

PR 20.0%(95%Cl:7.7-38.6) PFS 89.0days(95%Cl:71.0-217.0)

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)Interstitial pneumonia or pulmonary fibrosis detectable on chest X-ray 2)Patients with superior vena cava syndrome 3)History of uncontrollable diabetes mellitus, active angina pectoris, recent myocardial infaction, and recent brain infarction 4)History of active infection 5)History of severe psychological disease 6)Hystory of active double cancer 7)History of severe drug allergy 8)History of severe heart disease 9)Patients with immunotherapy or vaccine therapy 10)Patients whose participation in the trial is judged to be inappropriate by the attending doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
Progression free survival Overall survival 1 year survival rate Safety QO
© Copyright 2025. All Rights Reserved by MedPath